1. Guest, read the 'News in Brief' post for w/c 17th June by clicking this link.
    Dismiss Notice

Public Chemotherapy-free ‘cancer vaccine’ moves from mice to human trials at Stanford

Discussion in 'Health News and Research unrelated to ME/CFS' started by Ron, Mar 27, 2018.

  1. Ron

    Ron Established Member (Voting Rights)

    Likes Received:

    A few excerpts from the article:

    "A recent Stanford cancer study that cured 97 percent of mice from tumors has now moved on to soliciting human volunteers for a new cutting-edge medical trial."

    "The trial is part of a gathering wave of research into immunotherapy, a type of treatment that fights cancer by using the body's immune system to attack tumors."

    "The treatment is not a true vaccine that creates lasting immunity, but it does feature a vaccine-like injection carrying two immune-stimulators that activate the immune system's T cells to eliminate tumors throughout the body."

    "Levy, along with Stanford instructor of medicine Idit Sagiv-Barfi, published their study on the cancer-curing effect of immunotherapy on January 31 in Science Translational Medicine. Levy is a pioneer in the field of cancer immunotherapy having contributed to the development of rituximab, one of the first monoclonal antibodies approved for use as an anti-cancer treatment in humans."
    Solstice, Barry, BurnA and 5 others like this.

Share This Page